To study the tumor cell-intrinsic role of Nrp2 in the aggressive form of CRC, we aimed to generate a CRC model closely resembling the clinical correlate, EMT-high/stroma-rich CMS4 subtype. This evidence concerns the gene NRP2 and colorectal carcinoma.